ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,193,000 | +233.8% | 116,300 | +108.4% | 0.00% | +100.0% |
Q2 2019 | $657,000 | -3.9% | 55,800 | +11.4% | 0.00% | 0.0% |
Q1 2019 | $684,000 | +29.5% | 50,100 | -2.7% | 0.00% | 0.0% |
Q4 2018 | $528,000 | -41.3% | 51,500 | -4.6% | 0.00% | 0.0% |
Q3 2018 | $899,000 | -2.7% | 54,000 | -7.7% | 0.00% | 0.0% |
Q2 2018 | $924,000 | +14.1% | 58,500 | -8.3% | 0.00% | 0.0% |
Q1 2018 | $810,000 | +6.4% | 63,800 | -4.1% | 0.00% | 0.0% |
Q4 2017 | $761,000 | -6.6% | 66,500 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $815,000 | +7.1% | 66,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $761,000 | -45.0% | 66,500 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $1,383,000 | -4.2% | 66,500 | -4.2% | 0.00% | 0.0% |
Q4 2016 | $1,444,000 | -36.5% | 69,400 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $2,274,000 | +22.7% | 69,400 | -6.5% | 0.00% | +33.3% |
Q2 2016 | $1,853,000 | -1.2% | 74,200 | -3.1% | 0.00% | 0.0% |
Q1 2016 | $1,876,000 | -30.1% | 76,600 | -5.8% | 0.00% | -25.0% |
Q4 2015 | $2,685,000 | +842.1% | 81,300 | +834.5% | 0.00% | – |
Q3 2015 | $285,000 | -11.2% | 8,700 | -21.1% | 0.00% | – |
Q1 2015 | $321,000 | 0.0% | 11,032 | 0.0% | 0.00% | – |
Q4 2014 | $321,000 | – | 11,032 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |